Skip to content

Thoraflex™ Hybrid THP2830X100ARecalls & reported problems

Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant

All models of Thoraflex Hybrid (33)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05037881026718), received between May 22, 2024 and Apr 24, 2025 — classified as 4 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information3
  • Human-Device Interface Problem1
  • Obstruction of Flow1
  • Patient-Device Incompatibility1

Patient problems

  • Thrombosis/Thrombus2
  • Insufficient Information1
  • Ischemia1
  • Obstruction/Occlusion1
  • Rupture1
  • Vascular Dissection1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 24, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    ON POST OPERATIVE DAY 4 ((B)(6) 2025), SITE REPORTED AN ADVERSE EVENT (AE) OF FALSE LUMEN THROMBOSED, WITH IMPROVED EXPANDED TRUE LUMEN EXTENDING FROM THE PROXIMAL ASCENDING AORTA TO THE PROXIMAL ABDOMINAL AORTA, AT THE LEVEL OF L1 VERTEBRAL BODY. PATIENT OUTCOME: THE THROMBOSIS IS ONGOING, UNRESOLVED WITH NO TREATMENT AND IS ONGOING AT TIME OF REPORTING. THE ADVERSE EVENT IS CONSIDERED MODERATE IN SEVERITY. THE SUBJECT CONTINUED IN THE STUDY. CONCOMITANT MEDICATIONS INCLUDE ASPIRIN, LABETALOL AND NICARDIPINE.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 21897697 ↗
  • InjuryFeb 18, 2025Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information

    PATIENT IS PART OF CLINICAL TRIAL (B)(6). THE ONLY INFORMATION THAT SITE HAVE ENTERED INTO THE EDC (ELECTRONIC DATA CAPTURE SYSTEM) IS THE EVENT TERM, START DATE OF THE EVENT. THE SITE WILL BE REQUESTED TO UPDATE THE ADVERSE EVENT PAGE AND ANY RELEVANT PAGES IN THE EDC. ON (B)(6) 2024 THE PATIENT DEVELOPED THE MEDICAL EVENT OF A STENT GRAFT INDUCED NEW ENTRY (SINE) THIS REPORT IS BEING SUBMITTED AS FOLLOW UP # 1 FOR MANUFACTURING REPORT 9612515-2025-00017 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).

    Patient problems: Insufficient Information; Rupture

    MAUDE report 21397946 ↗
  • InjuryAug 28, 2024Human-Device Interface Problem; Insufficient Device Problem Information; Human-Device Interface Problem; Insufficient Device Problem Information

    EVENT REPORTED: 06 AUG 24. IMPLANT DATE: (B)(6) 2024. EXTEND-OO1 (NCT05639400) POST MARKET APPROVAL STUDY. EVENT DETAILS AS REPORTED, THE PATIENT THROMBUS IN ASCENDING AORTA SEEN WITH COMPRESSION INTO LEFT ATRIUM. THE THROMBUS OCCURRED OF (B)(6) 2024. THORAFLEX HYBRID WAS IMPLANTED ON (B)(6) 2024. NO DISTAL SEAL WAS INTENDED DUE TO A PLANNED EVAR EXTENSION AND NO DISTAL SEAL WAS OBTAINED. NO ENDOLEAK WAS PRESENT AT THE END OF THE PROCEDURE. DELIVERY OF THE THORAFLEX HYBRID WAS SUCCESSFUL, DEPLOYED IN PLANNED LOCATION AND WITHDRAWAL OF DELIVERY SYSTEM WAS SUCCESSFUL. NO DEVICE DEFICIENCIES OCCURRED DURING THE INDEX TH PROCEDURE. THE CLINICIAN/SITE HAVE REPORTED THIS EVENT AS NOT RELATED TO DEVICE AND POSSIBLY RELATED TO PRE-EXISTING CONDITION; RELATIONSHIP TO PROCEDURE NOT PROVIDED AS YET. DURING THEIR REGULAR REVIEW OF EXTEND ADVERSE EVENTS, THE STUDY MEDICAL MONITOR HAS REVIEWED AND MARKED THIS EVENT AS POSSIBLY RELATED TO THE DEVICE AND POSSIBLY RELATED TO PROCEDURE. THE SITE HAVE INDICATED THAT NO ACTION HAS BEEN TAKEN TO TREAT THE ADVERSE EVENT AT THIS TIME. PATIENT CURRENT STATUS IS UNRESOLVED AT THIS TIME.

    Patient problems: Ischemia; Thrombosis/Thrombus

    MAUDE report 20083382 ↗
  • InjuryMay 22, 2024Obstruction of Flow; Obstruction of Flow

    AS REPORTED: THE PATIENT HAD A SURGERY FOR A TOTAL ARCH REPAIR. THE PHYSICIAN SAID HIS TRUE LUMEN WAS OCCLUDED AND THEY WERE GOING BACK TO EXTEND THE THORAFLEX IN A LAST-DITCH EFFORT CTA (COMPUTED TOMOGRAPHY ANGIOGRAPHY) WAS PERFORMED IT WAS CLEAR THAT A DISTAL NEW STENT ENTRY TEAR WAS PRESENT. THE PATIENT UNDERWENT ANOTHER SURGERY TO EXTEND THE THORAFLEX AND SEAL OFF THE ANEURYSM USING A COOK MEDICAL DISSECTION GRAFT (TX2), AS WELL AS PERFORM A THROMBECTOMY ON THE SUPERIOR MESENTERIC ARTERY, AS IT WAS COMPLETELY THROMBOSED. A COOK MEDICAL DISSECTION STENT WAS PLACED FROM THE COOK MEDICAL TX2 THORAFLEX EXTENSION TO THE BIFURCATION AND A KNICKER BOCKER TECHNIQUE WAS PERFORMED IN THE ZDEG (ZENITH DISSECTION ENDOVASCUALR GRAFT) USING A 46MM CODA BALLOON. THE DISSECTION WAS THEN STABILIZED USING THE SAME CODA BALLOON, THROUGH THE ZDES (ZENITH DISSECTION ENDOVASCULAR STENT). THE SUPERIOR MESENTERIC ARTERY, THE RIGHT RENAL ARTERY, AND LEFT RENAL ARTERY WERE STENTED SO ALL VITAL ORGANS COULD BE PERFUSED. THE LOWER EXTREMITIES AT THIS TIME ALSO WERE NOT BEING PERFUSED, THEREFORE GORE EXCLUDER LIMBS WERE PLACED AS "KISSING STENTS" FROM THE BILATERAL HYPOGASTRIC ARTERIES TO THE INFRARENAL AO

    Patient problems: Obstruction/Occlusion; Vascular Dissection

    MAUDE report 19368647 ↗

Other Hybrid stent graft, thoracic aortic lesion treatment devices

All Hybrid stent graft, thoracic aortic lesion treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page